Interestingly, in individuals with a parental history of AD, the CSF apoE levels correlate with those of PCSK9 [78], strengthening the hypothesis that PCSK9 induces the degradation of the brain apoE-receptors, leading to increased CSF apoE concentrations. This evidence concerns the gene PCSK9 and Alzheimer disease.